News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) To Settle NuvaRing Lawsuits For $100 Million


2/7/2014 7:02:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Merck & Co has agreed to pay $100 million to settle hundreds of lawsuits accusing the U.S. drugmaker of downplaying serious health risks associated with its NuvaRing contraceptive device, Bloomberg reported on Thursday, citing people familiar with the deal. The agreement, which would settle cases in federal and state courts, will be announced on Friday and pay about $58,000 per complaint, according to the report. Merck is facing more than 1,700 lawsuits accusing it of failing to adequately warn NuvaRing users or downplaying a potential increased risk of developing dangerous blood clots known as venous thromboembolism, according to a recent filing with the U.S. Securities and Exchange Commission.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at St. Louis Post-Dispatch
Read at Bloomberg
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES